Showing results (141-150 of 204) with videos related to

Sort By:
Pageof 21
Metabolism: Clinical and Experimental|October 23, 2008
Effect of 6-month supervised exercise on low-density lipoprotein apolipoprotein B kinetics in patients with type 2 diabetes mellitusMichael Stolinski, Saima Alam, Nicola C Jackson, et al.
The Proceedings of the Nutrition Society|June 5, 2020
Report of a member-led meeting: how stable isotope techniques can enhance human nutrition researchBarbara A Fielding, Bruce A Griffin, Wendy Hall, et al.
Antiviral Research|December 27, 2011
In vitro resistance selections using elvitegravir, raltegravir, and two metabolites of elvitegravir M1 and M4Nicolas A Margot, Rebecca M Hluhanich, Gregg S Jones, et al.
The Journal of Clinical Endocrinology and Metabolism|September 15, 2018
Lixisenatide Reduces Chylomicron Triacylglycerol by Increased ClearanceMartin B Whyte, Fariba Shojaee-Moradie, Sharaf E Sharaf, et al.
The Journal of Clinical Endocrinology and Metabolism|March 18, 2010
Treatment with recombinant human insulin-like growth factor (rhIGF)-I/rhIGF binding protein-3 complex improves metabolic control in subjects with severe insulin resistanceFiona M Regan, Rachel M Williams, Anna McDonald, et al.
Diabetes Care|May 20, 2011
Insulin detemir reduces weight gain as a result of reduced food intake in patients with type 1 diabetesSunil Zachariah, Ben Sheldon, Fariba Shojaee-Moradie, et al.
American Journal of Physiology. Endocrinology and Metabolism|April 6, 2002
Effect of IGF-I therapy on VLDL apolipoprotein B100 metabolism in type 1 diabetes mellitusEmanuel R Christ, Paul V Carroll, Elaine Albany, et al.
Antiviral Therapy|December 25, 2009
Adipocyte differentiation, mitochondrial gene expression and fat distribution: differences between zidovudine and tenofovir after 6 monthsMeg Boothby, Kirsty C McGee, Jeremy W Tomlinson, et al.
Diabetes|July 29, 2006
Effects of recombinant human IGF-I/IGF-binding protein-3 complex on glucose and glycerol metabolism in type 1 diabetesTero Saukkonen, Fariba Shojaee-Moradie, Rachel M Williams, et al.
The Journal of Clinical Endocrinology and Metabolism|September 10, 2004
Dose-dependent effects of recombinant human insulin-like growth factor (IGF)-I/IGF binding protein-3 complex on overnight growth hormone secretion and insulin sensitivity in type 1 diabetesTero Saukkonen, Rakesh Amin, Rachel M Williams, et al.
Pageof 21